regulus

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) – CNA Finance

Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]

June 9, 2015 ByTerry Chrisomalis AZN, biotech, biotech-stock, chief, health, president, regulus, therapeutics, xanthopoulos Comments Off read more

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept …

Major updates in the biotech sector over the past four trading days were on the pipeline and regulatory front from companies like Alkermes (ALKS – Analyst Report) and Amgen (AMGN – Analyst Report) among others.Recap of the Week’s Most Important Stories1. Alkermes’ experimental schizophrenia treatment, ALKS 3831, fared well in a mid-stage study. Earlier this year, the company had said […]

April 8, 2015 ByArpita Dutt biotechnology, catalyst, collaboration, company, gene, major, medicines, regulus, report, repros, university Comments Off read more